Abstract
Background and purpose
To evaluate the neutrophil-to-lymphocyte ratio (NLR) levels in the peripheral blood of patients with progressive supranuclear palsy (PSP), and to compare them with levels in patients with idiopathic Parkinson’s disease (PD) and healthy controls.
Methods
Twenty-one patients with probable PSP, 42 with PD, and 40 age-matched healthy volunteers were enrolled in the study. Demographic data and duration of disease, comorbid systemic disease, and smoking status were recorded. NLR was calculated by dividing neutrophil count by the lymphocyte count.
Results
The mean age of patients with PSP was 68.28 ± 8.7 years and the mean duration of disease was 5.09 ± 2.52 years. The mean age in PD group was 66.59 ± 9.54 years and 65.05 ± 6.52 years in the healthy volunteer group. There were no significant differences in ages between the PSP group and the other two groups (p = 0.498; p = 0.107, respectively). The PSP group consisted of four female and 17 male patients. The PD group comprised 19 female and 23 male patients. There were 18 female and 2 male in the healthy volunteer group. The mean NLR value in the PSP group was significantly higher than in the PD group and healthy controls (p = 0.023; p = 0.001, respectively). The mean NLR value in the PD group was not significantly different from the healthy controls (p = 0.593).
Conclusion
NLR values were found higher in the PSP group. The result of this study revealed the existence of peripheral inflammation in patients with PSP.
Similar content being viewed by others
References
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and serebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10(4):333–359
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552–563
Kovacs G (2015) Neuropathology of tauopaties: principles and practice. Neuropathol Appl Neurobiol 41(1):3–23
Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 60(6):647–657
Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. Jci1 27(10):3577–3587
Khandelwal PJ, Herman AM, Moussa CE-H (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238(1–2):1–11
Zahorec R (2001) Ratio of neutrophil to lymphocyte count: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14
Kuyumcu ME, Yeşil Y, Ozturk ZA, Kızılarslanoglu C, Atgul S, Halil M et al (2012) The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord 34(2):69–74
Rembach A, Watt AD, Wilson WL, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD, AIBL Research Group (2014) An increased neutrophil-lymphocyte ratio in Alzheimer’s disease is function of age and is weakly correlated with neocortical amyloid accumulation. J Neuroimmunol 273(1–2):65–71
Akıl E, Bulut A, Kaplan I, Ozdemir HH, Arslan D, Aluçlu MU (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. NeurolSci 36(3):423–428
Kücük E, Kocayiğit İ, Günel C, Düzenli H (2016) Neutrophil-to-lymphocyte ratio in occlusive vascular disease: the literature review of the past 10 years. World J Emerg Med 7(3):165–172
Ozbay I, Kahraman C, Balıkcı HH, Kucur C, Karaman NK, Ozkaya DP (2014) Neutrophil-to-lymphocyte ratio inpatients with peripheral vertigo: a prospective controlled clinical study. Am J Otolaryngol 35(6):699–702
Corriere T, Marca D, Cataudella E, Pulvirenti A, Stancanelli SA, Malatino L (2018) Neutrophil-to-lymphocyte ratio is a strong predictor of atherosclerotic carotid plaque in older adults. Nutr Metab Cardiovasc Dis 28(1):23–27
Woong Nam K, Min Kwon H, YeongJeong H, Ho Park J, Kim SH, Min Jeong S (2018) High neutrophil-to-lymphocyte ratio predict intracranial atherosclerosis in healthy population. Atherosclerosis 269:117–121
Zeng Z, Wang C, Wang B, Wang N, Yang Y, Guo S, Du Y (2019) Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression autoimmune encephalitis. Neurosci Lett 694:129–135
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang A et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorders society criteria. Mov Disord 32(6):853–864
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184
Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson S et al (2011) Cytokine expression and microbial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17(9):683–688
Hasson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U et al (2017) Blood based Nfl: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930–937
Donker Kaat L, Meeter LH, Chiu WZ, Melhem S, Boon AJW, Blennow K et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinson Relat Disorders 56:98–101
Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian symptoms. J Neurol Neurosurg Psychiatry 86(11):1240–1247
Olsson B, Constantinescu R, Holberg B, Andreassen N, Blennow K, Zetterberg H (2013) The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord 28(13):1882–1885
Ferrari CC, Tarelli R (2011) Parkinson’s disease and systemic inflammation. Parkinson’s Dis 436813. https://doi.org/10.4061/2011/436813
Azab B, Camacho-Rivera M, Taioli E (2014) Average values and racial differences of neutrophil-lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 9(11):e112361
Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L (2014) Neutrophil to lymphocyte ratio in relation to risk of all cause of mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis observational studies. Atherosclerosis 234(1):206–213
Eryıgıt U, AltunayogluCakmak V, Sahin A, Tatlı O, Paslı S, Gazioglu G et al (2017) The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorage and migraine. Am J Emerg Med 35(9):1276–1280
Ucar Ataç C, Cokal BG, Artık UHA, Inan LE, Yoldas TK (2017) Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38(2):287–293
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The local ethics committee approved the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
None of the parts of this original article entitled as “The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study” has had prior or duplicate publication or submission elsewhere.
Rights and permissions
About this article
Cite this article
Inci, I., Kusbeci, O.Y. & Eskut, N. The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study. Neurol Sci 41, 1233–1237 (2020). https://doi.org/10.1007/s10072-019-04208-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-04208-4